The effect of i.v. administration of ionophores on metabolism in ruminants was investigated in two experiments. In Exp. 1, four Angus heifers were assigned randomly to receive i.v. monensin (18 rag, n = 2) or vehicle (control, n = 2). Samples were collected from indwelling vena cava cannulas from -60 to 240 min. Concentrations of K, Mg (P < .05) and P (P < . 10) were lower and glucose (GLU) and free fatty acids (FFA) were higher (P < .05) in monensin-treated than in control heifers. Serum insulin (INS) initially declined and subsequently increased (P < .05) following monensin administration. A second experiment was conducted to determine the effect of a higher dose of monensin and the effect of lasalocid on minerals and metabolites. Angus (n = 3) and Hereford (n = 3) steers were randomly assigned to treatments in two 3 x 3 latin square designs. Treatments were i.v. administration of monensin, lasalocid or vehicle (ethanol) administered on three consecutive days. Administration of monensin, but not vehicle or lasalocid, resulted in ataxia, hypernea, polyuria and anorexia for approximately 2 h. Plasma concentrations of K, P and Mg were suppressed (P < .05) by monensin, but not by vehicle or lasalocid administration. The decrease in K was preceded by a transient increase in K 15 rain after administering monensin. Concentrations of GLU and FFA increased (P < .05) following monensin administration. Concentrations of INS were lower from 60 to 120 min and greater at 180 and 240 rain compared with -60 to 0 min from monensin administration (P < .05). These results provide first evidence of an effect of monensin on metabolism in ruminants independent of alterations in ruminal microbial metabolism.
Introduction
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2 Dept. of Anim. Sci. Received October 26, 1987 . Accepted February 16, 1988 gain(or) feed efficiency in ruminants (Potter et al., 1976; Bergen and Bates, 1984) . Probable modes of action by which monensin directly alters ruminal microbial metabolism were reviewed by Schelling (1984) . These include an increase in propionate and a decrease in acetate and butyrate production, modification of feed intake, ruminal fill and rate of passage, and changes in protein utilization and gas production. The observation that feeding ionophores or a high-energy diet will decrease the age and weight at puberty in beef heifers substantiates the importance of ionophore effects on ruminal propionate production (Moseley et al., 1977; McCartor et al., 1979) . Infusion of propionate into ruminants increases concentrations of glucose, glucagon, growth hormone (Sartin et al., 1985) and insulin (McAtee and Trenkle, 1971; Johnson et al., 1982; Istasse et al., 1987) . Propionate and (or) the propionate-induced increase in insulin may mediate some of the positive effects of ionophore feeding on metabolism of ruminants. An alternative hypothesis is that a portion of the response to ionophores may be due to changes in metabolism through mechanism(s) that do not involve alterations in ruminal microbial metabolism, because 36 to 50% of [14C] monensin is absorbed by ruminants (Davison, 1984; Donoho, 1984) . The objectives of these experiments were to determine changes in circulating minerals, metabolites and hormones following i.v. administration of monensin and lasalocid.
Materials and Methods
General. Two experiments were conducted using 10-to 13-mo-old Angus and Hereford heifers and steers. During experimental procedures, heifers or steers were tethered in individual stalls in a ventilated barn. Animals were cannulated and acclimated to the stalls and tethers at least 48 h prior to initiating experimental procedures. Cannulas were inserted into the vena cava via the external jugular vein through a 12-gauge needle and secured with elastic tape.
Selected blood samples were analyzed for insulin (INS), growth hormone (GH), luteinizing hormone (LH), glucose (GLU), free fatty acids (FFA), Ca, K, Na, Mg and P. Blood samples were collected into plain glass tubes (FFA, INS, GH, LH) or evacuated glass tubes 3 containing either potassium oxalate and sodium fluoride (GLU) or sodium heparin (Ca, K, Na, Mg, P). Blood samples were placed on ice immediately after collection and refrigerated at 4~ until centrifugation at 3,000 • g for 20 rain the same or the next day for plasma and serum, respectively. Plasma and serum were stored at -20~ until analyzed. Experiment 1. Four Angus heifers (397 + 5 kg) were randomly assigned during November, 1986 to receive i.v. monensin (18 mg in 1 ml vehicle, n = 2) or vehicle (1 ml absolute ethanol, n = 2). Beginning at 0900, samples were collected at --75, -60, -45, -30, -15, 0, 8, 15, 30, 45, 60, 75, 90, 105, 120, 180 and during the study, steers were fed 3.4 kg/d of a barley-peanut hull-based diet (Table 1) . Analyses of LH concentrations were conducted on steers (n = 3) from only one of the latin squares.
Hormone, Metabolite and Mineral Assays.
Serum INS was assayed by validated procedures (Ray et al., 1983; Armstrong and Britt, 1987) . Potency of bovine INS 4 used as standards was 26.6 /aU/ng. Intraassay coefficients of variation (CV) were 6.7 and 12.6% for Exp. 1 and 2, respectively. Serum concentrations of LH were determined as described by Barnes et al. (1981) . Intraassay CV for Exp. 2 was 7.7%.
Serum GH was measured by a heterologous radioimmunoassay using a rabbit anti-ovine GH serum (AFP CO123080) and antigens (ovine GH, AFP-8758C; bovine GH, AFP 534OB) s. Specificity and cross-reactivities of this antiserum have been documented (PHAC, 1987) . Ovine GH was used as the radio-ligand and as standards.
Radioiodinated ovine GH was prepared by adding 25 /ag chloramine T (.05 M KPO 4, pH 7.5) to a reaction vial containing 40/~1 buffer (.5 M NaaPO 4, pH 7.5), 3/~g ovine GH in 10 gl .01 M NaHCO3 (pH 7.5) and 1.0 mCi 12si. The reaction was stopped by adding 125 pg Na metabisulfate (.05 M KPO4, pH 7.5). The mixture was then transferred to a column (1.0 X 10 cm) of Bio-Gel P-606 (7 cm), P-106 (1.5 cm) and AG 1-• 8 resin 6 (1.5 cm) equilibrated and etuted with 1% bovine serum albumin (BSA)--.01 M phosphate-buffered saline (PBS), pH 7.5. Immunologic performance of labeled GH was predicted by using the talc-resintrichloroacetic acid (TCA) test (Tower et al., 1980) . Antiserum to ovine GH was diluted 1: 40,000 in .05 M ethylenediaminetetraacetate (EDTA)-PBS, pH 7.0, in 1% normal rabbit serum and dispensed into assay tubes con- raining .4 ml 1% BSA-PBS, pH 7.0, and .1 ml serum or standard. Immediately following addition of antiserum, .1 ml of lzsI ovine GH (20,000 cpm) was added. Twenty-four hours later, .2 ml sheep anti-rabbit gamma-globulin serum diluted 1:8 in .05 M EDTA-PBS, pH 7.0, and .8 ml 6% polyethylene-glycol were added and allowed to incubate 1 h before centrifugation (1,700 • g for 25 min). Total binding (cpm in buffer controt/cpm in total count tubes) was 31.5%. Displacement of 12SGH by increasing volumes (25 to 300 #1) of ovine or bovine sera and by increasing concentrations of bovine GH was parallel to the standard curve (ovine GH, range .3125 to 10 ng/tube). Ovine or bovine GH (2.5 ng) was consistently recovered from .2 ml ovine or bovine serum (96 to 109%). Assay sensitivity, defined as 90% of total binding, was .2 ng. Intraassay CV was 4.7 and 4.5% for replicates from serum pools containing 5.2 and 6.0 ng/ml, respectively. Plasma GLU was determined by an automated method 7 employing a membraneimmobilized glucose oxidase enzyme coupled to an electrochemical sensor. Serum FFA were measured by an enzymatic, colorimetric method s. Briefly, FFA were activated to a coenzyme A ester and oxidized to produce hydrogen peroxide. Hydrogen peroxide was acted on by peroxidase in the presence of 3-methyl-N-ethyl-N-/3-hydroxyethyl-aniline and 4-aminotipyrine to form a product that was read at 550 nm. Concentrations of P, Mg, Ca and Na were determined by atomic absorption spectrophotometry 9. Plasma concentrations of P were determined by the procedure of Fiske and Subbarow (1925) .
Statistical Analyses. All analyses were conducted using the General Linear Models Procedure (SAS, 1982) . In both experiments, analyses were performed by split-plot analysis of variance for repeated measurements (Gill and Hafs, 1971) . The model used for Exp. 1 included treatment (monensin vs vehicle), heifer within treatment, time and the time x treatment interaction. The main effect of treatment was tested using the heifer within treatment mean square as the error term. Data from Exp. 2 were analyzed as described by Steel and Torrie (1980) for a latin square design. The model used included (df in parenthesis) square (1), day within square (4), steer within square (4), treatment (2), interaction among square, day, steer and treatment (6), time (6) and the treament • time interaction (12). Time and the time x treatment interaction were tested using the residual as the error mean square. All other components, including treatment, were tested using the four-way interactions as the error mean square. When treatment was found to be significant, the following single degree of freedom comparisons were made: control vs monensin and control vs lasalocid. When the treatment x time interaction was found to be significant, the effect of time within treatment was tested using Duncan's multiple range test (Steel and Torrie, 1980) .
Results

Experiment 1. Changes in K, P and Mg
following vehicle or monensin administration are depicted in Figure 1 . The main effect of treatment was not significant for K, P or Mg. A significant treatment • time interaction (P < .01) was observed for K and Mg. Potassium was lower in monensin-treated than in vehicletreated heifers from 30 to 90 min after treatment, whereas Mg was decreased from 105 to 180 min after monensin, but not after vehicle, administration (Figure 1 ). Phosphorus tended (P < .10) to be lower in monensin than in control heifers from 30 to 90 min after treatment. Plasma concentrations of Ca (data not shown) and Na (363 + 14 mg/dl) were similar (P > .20) in all heifers following vehicle or monensin administration.
Concentrations of GLU, FFA and INS before and after injection of monensin or vehicle are presented in Figure 2 . Glucose and FFA were elevated (P < .01) from 15 to 180 and 15 to 90 min, respectively, from injection of monensin, but not vehicle. Serum concentrations of INS were initially suppressed (15 rain) and subsequently elevated (30 to 180 rain) following injection of monensin (P < .05).
Intravenous administration of monensin or vehicle did not noticeably alter behavior of heifers. Appetite and qualitative estimates of behavior were similar in all heifers.
Experiment 2. Intravenous administration of
monensin, but not of lasalocid or vehicle, resulted in ataxia and hypernea for approximately 1 h and polyuria for approximately 2 h. Anorexia occurred consistently for at least 240 min after monensin administration. Carry-over affects of previous treatment on appetite were not observed because daily feed consumption was similar among treatments.
Changes in K, P and Mg following i.v.
administration of monensin, lasalocid or vehicle are depicted in Figure 3 . A treatment • time interaction (P < .02) was observed for each variable, but the treatment effect was significant only for K (control vs monensin, P < .01). Potassium was elevated consistently (P < .05) at 15 min after monensin administration and suppressed (P < .05) from 30 to 240 min after monensin administration. Plasma P and Mg were suppressed (P < .05) from 30 to 120 min after monensin administration. Concentrations of Ca were not altered (P > .20) by injection of monensin, lasalocid or vehicle (data not shown). Plasma Na was not altered (P > .6) by treatment; mean concentrations (mg/dl)of Na were 304 + 2, 306 + 2 and 310 + 2 for steers injected with monensin, lasalocid and vehicle, respectively. Profiles of average GLU, FFA and INS following control, monensin or lasalocid administration are presented in Figure 4 . Plasma GLU and serum FFA were elevated in all samples taken after injection of monensin (15 to 240 min) compared with vehicle or lasalocid (P < .05). Glucose (mg/dl)ranged from 147 to 312 from 60 to 240 min after monensin administration, whereas GLU in control and lasalocid-treated steers during the same time interval were consistently less than 90. Serum INS was similar (P > .10) following vehicle or lasalocid administration; however, a treatment • time interaction (P < .05) was observed following monensin administrati,~ Injection of monensin initially suppressed (60 to 90 min) and later increased concentrations of INS (180 and 240 rain) compared with pretreatment values (-15 and 0 min; P < .05).
Average concentrations of GH and an individual profile of secretion of LH are shown in Figures 5 and 6 , respectively. Monensin tended (P < .10) to suppress GH (Figure 5 ), as concentrations were decreased in four of six steers following monensin administration. Serum LH was not affected by injection of vehicle or lasalocid; however, LH consistently declined from 45 to 120 rain after injection of monensin in the three steers from which samples were assayed (P < .05, Figure 6 ).
Discussion
The results reported herein provide the first evidence of an effect of monensin on metabolism in the ruminant independent of alterations in ruminal microbial metabolism. Intravenous administration of monensin elevated glucose and FFA and altered secretion of insulin. Alterations in insulin, glucose and FFA may reflect changes in body composition and, thus, in feed efficiency and gain. Oscar et al. (1987) reported that oral administration of rnonensin improved feed efficiency in steers and decreased fat content of carcasses.
Although cause and effect relationships cannot be determined from these experiments, changes in plasma minerals were probably indices of the cellular effects of monensin. Monensin causes a rapid increase in intracellular Na in exchange for protons or K (Pressman, 1976) all steers in Exp. 2 probably represents the efflux of K in response to the influx of Na, whereas the decrease in K that followed may indicate the influx of K due to stimulation of the Na-ATP pump. The failure to observe concomitant changes in plasma concentrations 33, .22 to .57, .20 to .43; .19 to .27, .17 to .28, .33 to .43; and .04 to .07, .03 to .06, .06 to .12 for vehicle-, monensin-and lasalocidtreated steers, respectively.
of Na and K probably is associated with the several-fold difference in extracellular Na and K concentrations.
Intravenous administration of monensin may have altered concentrations of glucose, FFA and insulin by a direct cellular mechanism and(or) an indirect mechanism involving changes in catecholamines, insulin or other metabolic hormones. Changes in intracellular pH and concentrations of Na could alter . Glucose, free fatty acids (FFA) and insulin concentrations in steers from -30 to 240 min from injection of vehicle (control) or monensin. Standard errors for glucose (mg/dl), FFA (peq/liter) and insulin (pU/ml) ranged from 2.9 to 3.8, 2.5 to 22.9, 2.4 to 3.6; 14 to 23, 18 to 282, 39 to 85; and 1.6 to 5.1, 1.4 to 43.2, 4.3 to 18.7 for vehicle-, monensin-and lasalocid-treated steers, respectively. cellular metabolism through alterations in concentrations of Ca ions, which are critical to stimulus-secretion coupling or release of hormones from cells following stimulation. Glucose-stimulated insulin release in vitro is inhibited by monensin in a dose-dependent fashion (Kanatsuka et al., 1987) . This effect was probably mediated through an inhibition of the glucose-induced decrease in intracellular pH and increase in Ca (Kanatsuka et al., 1987 Figure 5 . Average concentrations of growth hormone (GH) in steers following injection of vehicle (control), monensin or lasalocid. Standard errors for GH (ng/ml) ranged from 1.5 to 6.1, 1.2 to 11.1 and 1.2 to 6.3 for vehicle-, monensin-and lasalocid-treated steers, respectively. human transferrin recycling in K562 cells (human erythroleukemia; Stein et al., 1984) and causes a redistribution of epidermal growth factor receptors from the plasma membrane to an intracetlular compartment in lysosomes (King, 1984) .
Administration of monensin may have altered glucose, FFA, insulin and minerals through an indirect mechanism involving ~adrenergic stimulation. Monensin increases intracellular Na, which may result in increased availability of intracellular Ca by displacing intracellularly sequestered Ca or bringing extracellular Ca into the cell via an exchange diffusion carrier (Pressman and Fahim, 1982) . Hochman and Perlman (1976) Figure 6 . Pattern of LH secretion in an individual steer from -60 to 120 min from injection of vehicle, monensin or lasalocid.
